SALT LAKE CITY--(BUSINESS WIRE)--Seek Labs, a healthcare innovations company developing next-generation point-of-care molecular diagnostic systems and novel CRISPR-based gene therapies, announced ...

This new technology could one day significantly expand the market for gene-editing biotechs.

SALT LAKE CITY--(BUSINESS WIRE)--Seek Labs, a private TechBio company building a programmable disease response platform to detect, protect, and counter disease threats, has been awarded $2 million ...

Harvard Medical School research on how to improve NIPT through chromosomal phasing (DOI: 10.1038/s41598-022-14049-5); a pan-European paper on Nature Scientific Reports on transcriptomic profile in a ...

With the first medical therapy approved and systems like CRISPR-Cas showing up in complex cells, there’s a lot happening in the genome editing field. By Amber Dance/Knowable Magazine Published Jan 26, ...

Originally developed for gene editing, CRISPR-Cas systems have now become powerful molecular diagnostic tools. However, their widespread adoption in diagnostics has relied heavily on traditional ...

A lab course at UB is giving undergraduate biology students hands-on experience with CRISPR, a revolutionary gene-editing technique. CRISPR allows scientists to disable or alter specific sections of ...

HOUSTON and BOGOTÁ, Colombia, June 29, 2026 /PRNewswire/ -- IntelliGenome, Inc., a molecular diagnostics company advancing next-generation tuberculosis detection technologies, today announced that ...

An illustration of DNA broken into two pieces. A decade after CRISPR started to become a major tool in genetic research, a new generation of scientists is growing up with the technology. Even high ...

Scientists and academic researchers from the US, Italy, Pakistan, Malta and more European countries keep choosing Dante Labs to sequence samples for important studies. Topics include rare diseases, ...

Seek Labs’ Programmable Target Ablation Platform (PTAP), uses CRISPR-based constructs to selectively disrupt viral DNA or RNA at conserved genomic sites. Those targets are identified and continuously ...